Detalles de la búsqueda
1.
Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase.
Hepatology
; 78(5): 1558-1568, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37184202
2.
Etiological changes of liver cirrhosis and hepatocellular carcinoma-complicated liver cirrhosis in Japan: Updated nationwide survey from 2018 to 2021.
Hepatol Res
; 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38638067
3.
Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study.
J Gastroenterol Hepatol
; 2024 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38480009
4.
Global treatment rate and barriers to direct-acting antiviral therapy: A systematic review and meta-analysis of 146 studies and 1 760 352 hepatitis C virus patients.
Liver Int
; 43(6): 1195-1203, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36825358
5.
Development of Hepatocellular Carcinoma in Patients Aged 75-84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals.
J Infect Dis
; 226(3): 431-440, 2022 08 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32584386
6.
Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine.
Clin Gastroenterol Hepatol
; 20(4): 874-885.e4, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34089852
7.
Impact of the PNPLA3 genotype on the risk of hepatocellular carcinoma after hepatitis C virus eradication.
J Med Virol
; 94(10): 5007-5014, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35652276
8.
On-treatment gamma-glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients.
Liver Int
; 42(1): 59-68, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34687130
9.
Long-term hepatic function of patients with compensated cirrhosis following successful direct-acting antiviral treatment for hepatitis C virus infection.
J Gastroenterol Hepatol
; 37(2): 371-377, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34618379
10.
Long-term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by direct-acting antivirals.
J Gastroenterol Hepatol
; 37(1): 190-199, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34374128
11.
A case of severe COVID-19 with pulmonary thromboembolism related to heparin-induced thrombocytopenia during prophylactic anticoagulation therapy.
J Infect Chemother
; 28(8): 1208-1211, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35570112
12.
Outcomes of Sequential Therapy With Tenofovir Alafenamide After Long-term Entecavir.
Am J Gastroenterol
; 116(6): 1264-1273, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34074829
13.
Cure With Interferon-Free Direct-Acting Antiviral Is Associated With Increased Survival in Patients With Hepatitis C Virus-Related Hepatocellular Carcinoma From Both East and West.
Hepatology
; 71(6): 1910-1922, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31610027
14.
Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy.
J Infect Dis
; 221(3): 389-399, 2020 01 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31550363
15.
Hepatitis C Virus Cure Rates Are Reduced in Patients With Active but Not Inactive Hepatocellular Carcinoma: A Practice Implication.
Clin Infect Dis
; 71(11): 2840-2848, 2020 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-31777940
16.
Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B.
Am J Gastroenterol
; 115(2): 271-280, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31634265
17.
Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B.
Liver Int
; 40(7): 1578-1589, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32304611
18.
Ledipasvir and sofosbuvir for 12 weeks for hepatitis C virus genotype 2 infection: A propensity score matched analysis.
Hepatol Res
; 50(2): 174-181, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31634412
19.
Prevalence and characteristics of occult hepatitis B virus infection in Japanese human immunodeficiency virus-infected patients.
J Infect Chemother
; 26(1): 28-32, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31279522
20.
Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis.
J Hepatol
; 71(3): 473-485, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31096005